Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
David R. Withers, Matthew R. Hepworth, Xinxin Wang, Emma C. Mackley, Emily E. Halford, Emma E. Dutton, Clare Marriott, Verena Brucklacher-Waldert, Marc Veldhoen, Judith R. Kelsen, Robert N. Baldassano, Gregory F. Sonnenberg
Abstract
Open-access reader